Literature DB >> 20187104

Bronchoscopic instillation of activated recombinant factor VII to treat diffuse alveolar hemorrhage in a child.

Andrew A Colin, Mitra Shafieian, Martin Andreansky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187104     DOI: 10.1002/ppul.21178

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


× No keyword cloud information.
  5 in total

1.  Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm.

Authors:  Lars Heslet; Jørn Dalsgaard Nielsen; Steen Nepper-Christensen
Journal:  Biologics       Date:  2012-03-06

Review 2.  Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis.

Authors:  Jeong A Park
Journal:  Int J Mol Sci       Date:  2021-01-14       Impact factor: 5.923

Review 3.  Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients.

Authors:  Jeong A Park
Journal:  Korean J Pediatr       Date:  2016-03-31

4.  Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage.

Authors:  Hind Bafaqih; May Chehab; Suliman Almohaimeed; Farah Thabet; Abdulrahman Alhejaily; Mohammed AlShahrani; Mohammed A Zolaly; Abeer A Abdelmoneim; Ehab S Abd
Journal:  Ann Saudi Med       Date:  2015 May-Jun       Impact factor: 1.526

5.  Risk factors of diffuse alveolar hemorrhage after acute ischemic stroke treated with tissue-type plasminogen activator. The effectiveness of activated recombinant factor VII treatment.

Authors:  Yu Shimizu; Katsuhiro Tsuchiya; Norihiro Fujisawa
Journal:  Surg Neurol Int       Date:  2020-05-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.